Rhythm Pharmaceuticals, Inc. (RYTM)
115.34
-2.28
(-1.94%)
USD |
NASDAQ |
Dec 12, 10:08
Rhythm Pharmaceuticals Research and Development Expense (TTM): 165.86M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Gilead Sciences, Inc. | 5.734B |
| Terns Pharmaceuticals, Inc. | 76.99M |
| Altimmune, Inc. | 67.72M |
| Viking Therapeutics, Inc. | 222.48M |
| Cidara Therapeutics, Inc. | 131.82M |